#1
|
|||
|
|||
Ïðîôèëàêòèêà ÒÃÂ â íåéðîõèðóðãèè
Êòî â êóðñå, ñóùåñòâóþò ëè âìåíÿåìûå ïðîòîêîëû ïðîôèëàêòèêè Òà(òðîìáîçà ãëóáîêèõ âåí) è ÒÝËÀ â íåéðîõèðóðãèè (ïëàíîâîé è íåîòëîæíîé). Êîãî áû íå ñïðàøùèâàë, ÷åòêèõ ïîçèöèé â ýòîì âîïðîñå íåò. Õîòåëîñü áû, ÷òîáû áûëî ÷åòêî è ïî ñòåïåíè ðèñêà, êàê â American College of Chest Physicians (ACCP) consensus guidelines ( http://www.chestjournal.org/cgi/cont...6/3_suppl/338S ), íî òàì íåéðîõèðóðãè÷åñêèå îïåðàöèè â ïðîòèâîïîêàçàíèÿõ ..
|
#2
|
|||
|
|||
Ìû íàçíà÷àåì ïàöèåíòàì ñ óìåðåííûì è âûñîêèì ðèñêîì, êîòîðûå àêòèâíû ìåíåå òðåõ ÷àñîâ â ñóòêè, ÷åðåç 48 ÷àñîâ ïîñëå íåéðîõèðóðãè÷åñêèõ îïåðàöèé, áåç ãèïîàãóëÿöèè ïî ëàá. òåñòàì. Íî ÷åòêîãî ïðîòîêîëà âñå ðàâíî íåò, êîòîðûé áû çàùèòèë îò ïðåòåíçèé ñî ñòîðîíû íåéðîõèðóðãîâ è íà÷àëüñòâà. Òðîìáîýìáîëè÷åñêèå è ãåìîððàãè÷åñêèå îñëîæíåíèÿ ó íàñ ïîäàþòñÿ â ðàâíîé ñòåïåíè êàê óïóùåíèÿ àíåñòåçèîëîãîâ-ðåàíèìàòîëîãîâ.
|
#3
|
||||
|
||||
Ìû ñ ìîèìè êîëëåãàìè àíåñòåçèîëîãàìè îêîëî ïîëóãîäà íàçàä çàíèìàëèñü ïîèñêàìè îòâåòà íà ýòîò âîïðîñ. Ïîäîáíûõ ïðîòîêîëîâ ê ñîæàëåíèþ íå ñóùåñòâóåò. Áîëåå òîãî, íè îäèí èç ïðåïàðàòîâ, èñïîëüçîâàííûé äëÿ ïðîôèëàêòèêè, íå ñíèæàåò âíÿòíî ïðîöåíò ÒÝËÀ.
__________________
Ñ óâàæåíèåì, ×åðåáèëëî Âëàäèñëàâ Þðüåâè÷ |
#4
|
|||
|
|||
Ììì .. íó, ïîæàëóé íå ñîãëàøóñü, íàñ÷åò òîãî, ÷òî ïðîôèëàêòè÷ñêèå ÍÌà íå ñíèæàþò ÒÝËÀ. Íî äåéñòâèòåëüíî ñòðàííî, ÷òî äî ñèõ ïîð íåò íèêàêîé ÷åòêîé ïîçèöèè î òîì êîìó, êîãäà è â êàêîì âèäå íàçíà÷àòü ïðîôèëàêòèêó Òàó íåéðîõèðóðãè÷åñêèõ ïàöèåíòîâ ..
Âîò, íàïðèìåð, ÷òî íàïèñàë ìíå çíàêîìûé íåéðîõèðóðã èç Êåìáðèäæà : Öèòàòà:
|
#5
|
|||
|
|||
Öèòàòà:
Áóäòå äîáðû íåçàáóäòå ñ íàìè òîæå ïîäåëèòñÿ Ñ óâàæåíèåì, Ãèîðãèé Âèòàëüåâè÷ |
#6
|
||||
|
||||
Öèòàòà:
ß äóìàþ, ÷åòêèõ ðåêîìåíäàöèé íåò ïîòîìó, ÷òî åñëè íàçíà÷èòü ïðîôèëàêòè÷åñêè àíòèêîàãóëÿíòû - ðåçêî ïîâûñèòü ÷àñòîòó ãåìîððàãè÷åñêèõ îñëîæíåíèé, à íå íàçíà÷èòü - áîëüøå áîÿòüñÿ ÒÝËÀ è ÒÃÂ. Ïîýòîìó è íå íàçíà÷àþò. Êðîìå òîãî, ÿ íå âñòðå÷àë ðàáîò, äîêàçûâàþùèõ ýôôåêòèâíîñòü àíòèêîàãóëÿíòîâ äëÿ ïðîôèëàêòèêè ÒÝËÀ â ïåðèîïåðàöèîííîì ïåðèîäå ó íåéðîõèðóðãè÷åñêèõ áîëüíûõ. Îáùàëñÿ íà ýòó òåìó ñ ïðîô. Êîíäðàòüåâûì, ïðîô. Ïîëóøèíûì - îíè âîîáùå óòâåðæäàþò, ÷òî äîêàçàíî íåâîçìîæíîñòü ñíèçèòü ÷àñòîòó ÒÝËÀ íàçíà÷åíèåì íèçêîìîëåêóëÿðíûõ ãåïàðèíîâ.
__________________
Ñ óâàæåíèåì, ×åðåáèëëî Âëàäèñëàâ Þðüåâè÷ |
#7
|
|||
|
|||
Îíè óòâåðæäàþò êðàìîëüíûå âåùè. Ýôôåêòèâíîñòü ïåðèîïåðàöèîííîãî íàçíà÷åíèÿ ÍÌà äëÿ ïðîôèëàêòèêè Òàè ÒÝËÀ ó ïàöèåíòîâ ãðóïï ïîâûøåííîãî ðèñêà áûëî óáåäèòåëüíî äîêàçàíî â ìàñøòàáíûõ èññëåäîâàíèÿõ è ðåêîìåíäàöèè ïî èõ íàçíà÷åíèþ áûëè ïîìå÷åíû, êàê èìåþùèå âûñîêèé óðîâåíü äîêàçàòåëüíîé îáîñíîâàííîñòè ( http://www.guideline.gov/summary/sum...=9266&nbr=4960 ).
Äðóãîå äåëî, ÷òî âñå èçâåñòíûå ìíå ãàéäû îãðàíè÷èâàþò íàçíà÷åíèå àíòèêîàãóëÿíòîâ ó íåéðîõèðóðãè÷åñêèõ áîëüíûõ, â ñâÿçè ñ âûñîêèì ðèñêîì âíóòðè÷åðåïíîãî êðîâîèçëèÿíèÿ. Íåéðîõèðóðãè÷åñêèì ïàöèåíòàì â ïåðèîïåðàöèîííîì ïåðèîäå íå ïðîòèâîïîêàçàíà òîëüêî ïíåâìîêîìïðåññèÿ. Ïðèâåäó áåç ñîêðàùåíèÿ åùå íåáîëüøîé òåêñòîâûé áëîê ïî ñàáæó èç The Clinical Practice of Critical Care Neurology 2nd Ed, 2003 Öèòàòà:
|
#8
|
||||
|
||||
Ñïàñèáî, èíòåðåñíàÿ ññûëêà.
Öèòàòà:
Ïîéäó ïîèùó åùå ÷åãî-íèáóäü. Åñëè íàðîþ, ñîîáùó. À â ïîíåäåëüíèê ñ ðåàíèìàòîëîãàìè åùå ðàç îáñóäèì ýòó ïðîáëåìó. Äà, êñòàòè. Ó íàñ ýòî íå ñ÷èòàåòñÿ ðåàíèìàöèîííî-àíåñòåçèîëîãè÷åñêèì äåôåêòîì. Ýòî îáùàÿ ïðîáëåìà. Ñëîæíîñòåé âî âçàèìîïîíèìàíèè íåò. Áîëåå òîãî. Ýòî íå äîêàçàòåëüíî, íî ìû âîîáùå íå ïðîâîäèì â ñòàíäàðòíîì âåäåíèè ïàöèåíòà ïåðèîïåðàöèîííóþ ïðîôèëàêòèêó àíòèêîàãóëÿíòàìè. Òîëüêî ðàííÿÿ àêòèâèçàöèÿ. Íàçíà÷åíèå íèçêîìîëëåêóëÿðíîãî ãåïàðèíà - òîëüêî åñëè ïàöèåíò çàâèñàåò â ðåàíèìàöèè áîëåå ÷åì íà äâîå ñóòîê. Ñëàâà áîãó, ýòî áûâàåò êðàéíå ðåäêî . Ïðè 1600-1800 íåéðîõèðóðãè÷åñêèõ îïåðàöèé â ãîä, ÷àñòîòà ÒÝËÀ ñîâñåì íå èçìåíèëàñü ñ ìîìåíòà îòêàçà îò àíòèêîàãóëÿíòîâ.
__________________
Ñ óâàæåíèåì, ×åðåáèëëî Âëàäèñëàâ Þðüåâè÷ |
#9
|
|||
|
|||
Ó íàñ îáû÷íî ìíîãî ëåæà÷èõ áîëüíûõ. Ìíîãèå áîëüíûå ïîñòóïàþò èñõîäíî ñ òÿæåëûì íåâðîëîãè÷åñêèì äåôèöèòîì, äîñòàò÷íî ìíîãî áîëüíûõ áåðåì èç äðóãèõ áîëüíèö ñî ñôîðìèðîâàâøèìñÿ íåâðîëîãè÷åñêèì äåôèöèòîì (â ò.÷. âåãåòàòèêîâ è ñ ñèíäðîìîì "ìàëîãî ñîçíàíèÿ") åùå ó íàñ äîñòàò÷íî ìíîãî áîëüíûõ ñ èøåìè÷åñèìè èíñóëüòàìè, ïîýòîìó àíòèêîàãóëÿíòû èñïîëüçóåì äîñòàòî÷íî øèðîêî.
Ïîñëå íåéðîõèðóðãè÷åñêèõú îïåðàöèé ÍÌà íàçíà÷àåì òîëüêî ñïóñòÿ 48 ÷àñîâ áîëüíûì ñ âûñîêèì ðèñêîì ÒÝËÀ êîòîðûå àêòèâíû (íà íîãàõ) ìåíåå 3 ÷àñîâ â ñóòêè. |
#10
|
||||
|
||||
Êîëëåãè! Çíàêîìî ëè :
Prevention of Pulmonary Embolism by Combined Modalities of Thromboprophylaxis and Intensive Surveillance Protocol. CLINICAL STUDIES Neurosurgery. 54(5):1099-1103, May 2004. Misra, Mukesh M.D.; Roitberg, Ben M.D.; Ebersole, Koji B.A.; Charbel, Fady T. M.D. Abstract: OBJECTIVE: Deep vein thrombosis (DVT) is a known complication in neurosurgical patients. The protocols for the prevention of DVT and pulmonary embolism (PE) are not applied universally. Our goal was to review the incidence of DVT and PE in neurosurgical intensive care units (NSICUs) and to compare it with the incidence of DVT and PE in other intensive care units (ICUs) in the same hospital. METHODS: We retrospectively reviewed 5327 consecutive admissions in all intensive care units at the University of Illinois Hospital between July 2001 and June 2002. The NSICU had 1094 admissions, and all other ICUs combined had 4233 admissions. In our NSICU, every patient was administered DVT prophylaxis in the form of subcutaneous heparin and a sequential compression device if these treatments were not contraindicated. Lower-extremity venous Doppler ultrasonography was performed twice weekly in all NSICU patients. There was no routine use of DVT prophylaxis in the other ICUs, and no other ICUs performed routine lower-extremity venous Doppler ultrasonography. We compared the incidence of DVT and PE in the NSICU and the combined population of other adult ICUs. RESULTS: PE was diagnosed in 1 (0.09%) of 1094 patients in the NSICU and in 45 (1.06%) of 4233 patients in all other ICUs (P < 0.0001, Z = 5.34). DVT was diagnosed in 28 patients (2.55%) in the NSICU and in 238 patients (5.62%) in all other ICUs (P < 0.001, Z = 4.32). These values suggest a statistically significant difference in the incidence of DVT and PE in the NSICU compared with all other ICUs. CONCLUSION: We conclude that there was a significantly lower incidence of DVT and PE in the NSICU than in all other ICUs at our institution. DVT prophylaxis and twice-weekly lower-extremity venous Doppler screening in the NSICU have been found to be beneficial in decreasing the incidence of DVT and particularly effective in preventing PE. Copyright (C) by the Congress of Neurological Surgeons |
#11
|
||||
|
||||
ß íå ëþáëþ åòîò èñòî÷íèê, íî âñ¸ æå:
[Ññûëêè äîñòóïíû òîëüêî çàðåãèñòðèðîâàííûì ïîëüçîâàòåëÿì ] [Ññûëêè äîñòóïíû òîëüêî çàðåãèñòðèðîâàííûì ïîëüçîâàòåëÿì ] [Ññûëêè äîñòóïíû òîëüêî çàðåãèñòðèðîâàííûì ïîëüçîâàòåëÿì ] |
#12
|
|||
|
|||
Åâãåíèé Àëåêñàíäðîâè÷, ñïàñèáî, ññûëêà êëàññíàÿ. Ñòðàííî, ÷òî ÿ åå íå íàøåë ðàíüøå.
|